跳至主要内容
临床试验/ACTRN12615001365550
ACTRN12615001365550已完成未知

Feasibility study assessing the association between gut microbiota in healthy adults and antibody response to seasonal influenza vaccination

The Malaghan Institute of Medical Research0 个研究点目标入组 125 人开始时间: 2015年12月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
125

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 64 Years(—)
性别
All

入选标准

  • Participant is willing and able to give informed consent for participation in the trial.
  • Male or Female, aged 18-64 years
  • In the investigators' opinion, is able and willing to comply with all trial requirements

排除标准

  • They have had a known severe reaction or allergy to any components of the influenza vaccine.
  • They have any contra-indications to vaccination per recommendations of vaccine manufacturer.
  • They have a history of Guillain-Barre Syndrome within 6 weeks of receiving a previous influenza vaccine.
  • They have an impaired immune system that may confound immune response testing; i.e. any condition that impairs participant immune response through either the condition itself or through the treatment of the condition.
  • They have already received the 2016 seasonal influenza vaccine.
  • They have any other clinical condition which the investigator deems relevant for exclusion from the study.

研究者

相似试验

Feasibility study looking at the effects of Gut... | 临床试验